WAVE Life Sciences (WVE) Competitors $8.63 +0.53 (+6.54%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$8.39 -0.24 (-2.79%) As of 08/1/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock WVE vs. AXSM, LNTH, TLX, PCVX, MRUS, CYTK, ADMA, KRYS, ABVX, and MTSRShould you be buying WAVE Life Sciences stock or one of its competitors? The main competitors of WAVE Life Sciences include Axsome Therapeutics (AXSM), Lantheus (LNTH), Telix Pharmaceuticals (TLX), Vaxcyte (PCVX), Merus (MRUS), Cytokinetics (CYTK), ADMA Biologics (ADMA), Krystal Biotech (KRYS), Abivax (ABVX), and Metsera (MTSR). These companies are all part of the "pharmaceutical products" industry. WAVE Life Sciences vs. Its Competitors Axsome Therapeutics Lantheus Telix Pharmaceuticals Vaxcyte Merus Cytokinetics ADMA Biologics Krystal Biotech Abivax Metsera WAVE Life Sciences (NASDAQ:WVE) and Axsome Therapeutics (NASDAQ:AXSM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Which has higher earnings & valuation, WVE or AXSM? WAVE Life Sciences has higher earnings, but lower revenue than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than WAVE Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWAVE Life Sciences$108.30M12.68-$97.01M-$0.84-10.27Axsome Therapeutics$385.69M13.15-$287.22M-$5.77-17.85 Does the media refer more to WVE or AXSM? In the previous week, WAVE Life Sciences had 8 more articles in the media than Axsome Therapeutics. MarketBeat recorded 15 mentions for WAVE Life Sciences and 7 mentions for Axsome Therapeutics. Axsome Therapeutics' average media sentiment score of 1.22 beat WAVE Life Sciences' score of 0.04 indicating that Axsome Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment WAVE Life Sciences 2 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Axsome Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, WVE or AXSM? WAVE Life Sciences has a beta of -0.95, suggesting that its share price is 195% less volatile than the S&P 500. Comparatively, Axsome Therapeutics has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Is WVE or AXSM more profitable? WAVE Life Sciences has a net margin of 0.00% compared to Axsome Therapeutics' net margin of -64.39%. WAVE Life Sciences' return on equity of -78.45% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets WAVE Life SciencesN/A -78.45% -41.51% Axsome Therapeutics -64.39%-272.80%-36.69% Do institutionals & insiders hold more shares of WVE or AXSM? 89.7% of WAVE Life Sciences shares are held by institutional investors. Comparatively, 81.5% of Axsome Therapeutics shares are held by institutional investors. 24.0% of WAVE Life Sciences shares are held by company insiders. Comparatively, 22.3% of Axsome Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts prefer WVE or AXSM? WAVE Life Sciences currently has a consensus price target of $20.36, suggesting a potential upside of 135.89%. Axsome Therapeutics has a consensus price target of $172.33, suggesting a potential upside of 67.28%. Given WAVE Life Sciences' higher probable upside, research analysts plainly believe WAVE Life Sciences is more favorable than Axsome Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score WAVE Life Sciences 0 Sell rating(s) 1 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.93Axsome Therapeutics 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 1 Strong Buy rating(s) 3.06 SummaryWAVE Life Sciences beats Axsome Therapeutics on 9 of the 17 factors compared between the two stocks. Get WAVE Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WVE vs. The Competition Export to ExcelMetricWAVE Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.29B$3.00B$5.48B$9.52BDividend YieldN/A2.43%4.73%4.08%P/E Ratio-9.5917.6228.6723.80Price / Sales12.68178.97373.5466.64Price / CashN/A41.9535.4557.96Price / Book9.818.508.275.55Net Income-$97.01M-$55.06M$3.24B$259.03M7 Day Performance2.74%-3.98%-3.69%-4.59%1 Month Performance27.85%9.59%4.33%4.46%1 Year Performance45.29%6.72%25.95%18.03% WAVE Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WVEWAVE Life Sciences4.7497 of 5 stars$8.63+6.5%$20.36+135.9%+40.1%$1.29B$108.30M-9.59240News CoverageEarnings ReportAnalyst ForecastAXSMAxsome Therapeutics4.8236 of 5 stars$101.20-3.6%$172.33+70.3%+19.8%$4.99B$432.16M-17.56380Positive NewsUpcoming EarningsLNTHLantheus4.6154 of 5 stars$71.24+0.4%$131.20+84.2%-28.4%$4.92B$1.54B20.19700News CoverageUpcoming EarningsAnalyst RevisionTLXTelix PharmaceuticalsN/A$13.96+0.5%$22.33+60.0%N/A$4.72B$516.72M0.00N/AGap DownPCVXVaxcyte2.2402 of 5 stars$35.76-1.3%$136.50+281.8%-58.0%$4.59BN/A-8.91160News CoveragePositive NewsUpcoming EarningsMRUSMerus2.6948 of 5 stars$66.06+0.6%$86.40+30.8%+25.1%$4.58B$54.73M-16.2137News CoverageCYTKCytokinetics4.0154 of 5 stars$37.15-0.4%$70.92+90.9%-36.6%$4.44B$18.47M-7.03250News CoverageUpcoming EarningsAnalyst ForecastInsider TradeADMAADMA Biologics4.2926 of 5 stars$18.17+5.0%$27.67+52.3%+57.7%$4.31B$459.38M21.24530Upcoming EarningsKRYSKrystal Biotech4.8885 of 5 stars$148.94-0.7%$211.33+41.9%-21.0%$4.30B$333.45M35.77210Upcoming EarningsABVXAbivax3.6107 of 5 stars$67.02-3.9%$80.00+19.4%+511.7%$4.26BN/A0.0061News CoverageAnalyst ForecastGap DownHigh Trading VolumeMTSRMetseraN/A$39.67+0.0%$55.00+38.6%N/A$4.17BN/A0.0081News CoverageEarnings ReportLockup ExpirationAnalyst RevisionGap Up Related Companies and Tools Related Companies AXSM Alternatives LNTH Alternatives TLX Alternatives PCVX Alternatives MRUS Alternatives CYTK Alternatives ADMA Alternatives KRYS Alternatives ABVX Alternatives MTSR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WVE) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WAVE Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share WAVE Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
